Accessible vision care for everyone — a 90-second self-serve vision test
123 See, Inc. is developing a gaze-independent, contactless autorefractor technology (GIPR) for deployment in self-serve, autonomous vision exam kiosks. The kiosk delivers a free 90-second vision test and generates a doctor-verified prescription sent directly to the user's email. By partnering with optical retailers, technology companies, and eye doctors, 123 SEE aims to expand access to vision care through a growing nationwide network of kiosks in high-traffic, accessible locations. The company's novel configuration uses commonly available low-cost components and can be manufactured at a fraction of the cost of commercial autorefractors.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountNo funding data available yet.
Know something? Help us improve our data.
Create a free account to see which investors have funded this company.

operates in the healthcare industry focusing on biotechnology business
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
Healthcare company in Europe
Mehiläinen is a leading Finnish private healthcare company providing medical, health, and special...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Klick Health is a healthcare marketing and commercialization agency serving life sciences and pha...